Are Investors Keen On Selling Holdings In Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP)?
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) traded at $1.41 at close of the session on Tuesday, March 19, made a downward move of -4.08% on its previous day’s price. Looking at the stock we see that its previous close was $1.47 and the beta (5Y monthly)